[ FDA DRUG SHORTAGES TRACKER ]

A drug shortage is a quality failure with a body count.

Live FDA drug shortage data (openFDA), grouped by status, availability, and therapeutic area. The FDA’s own root-cause analysis puts manufacturing and quality problems at the centre of the shortage crisis — which is why SPEQ treats the shortage list as a quality-system signal, not just a supply-chain one.

1,000
Active shortages tracked
789
Current
205
To be discontinued
196
Flagged unavailable
20% flagged unavailable · latest update 2026-07-27 · source: openFDA drug/shortages
NEW SHORTAGES POSTED · MONTHLY

By initial FDA posting date. openFDA lists active shortages, so older cohorts thin as entries resolve.

ACTIVE SHORTAGES BY THERAPEUTIC CATEGORY · TOP 10
WHY THIS SITS UNDER QUALITY, NOT LOGISTICS

The FDA’s 2019 report Drug Shortages: Root Causes and Potential Solutions found the dominant drivers are not scarcity of raw materials but a lack of incentives to produce, and manufacturing/quality problems that force production to stop. Mature quality systems — the difference a QMM assessment measures — are what keep a line running.

The economics of quality →FDA QMM framework →
Reset
1,166 matching shortages
DrugCompanyTherapeutic areaAvailabilityStatusPosted
Lidocaine Hydrochloride InjectionInjectionHikma Pharmaceuticals USA, Inc.AnesthesiaAvailableCurrent2018-06-13
Remifentanil Hydrochloride InjectionInjectionHikma Pharmaceuticals USA, Inc.Analgesia/AddictionAvailableCurrent2022-06-28
Methotrexate Sodium InjectionInjectionHikma Pharmaceuticals USA, Inc.RheumatologyAvailableCurrent2023-03-13
Lisdexamfetamine Dimesylate CapsuleCapsuleHikma Pharmaceuticals USA, Inc.PsychiatryLimitedCurrent2023-07-14
Promethazine Hydrochloride InjectionInjectionHikma Pharmaceuticals USA, Inc.Analgesia/AddictionAvailableCurrent2023-11-21
Lisdexamfetamine Dimesylate CapsuleCapsuleHikma Pharmaceuticals USA, Inc.PsychiatryLimitedCurrent2023-07-14
Cefotaxime Sodium Powder, for SolutionPowder, For SolutionHikma Pharmaceuticals USA, Inc.Anti-InfectiveUnavailableCurrent2015-02-17
Ifosfamide InjectionInjectionHikma Pharmaceuticals USA, Inc.OncologyAvailableCurrent2026-06-12
Valproate Sodium InjectionInjectionHikma Pharmaceuticals USA, Inc.NeurologyAvailableCurrent2020-12-30
Promethazine Hydrochloride InjectionInjectionHikma Pharmaceuticals USA, Inc.Analgesia/AddictionUnavailableCurrent2023-11-21
Morphine Sulfate InjectionInjectionHikma Pharmaceuticals USA, Inc.Analgesia/AddictionAvailableCurrent2017-11-03
Furosemide Oral SolutionOral SolutionHikma Pharmaceuticals USA, Inc.CardiovascularLimitedCurrent2026-03-31
Lisdexamfetamine Dimesylate CapsuleCapsuleHikma Pharmaceuticals USA, Inc.PsychiatryLimitedCurrent2023-07-14
Lorazepam InjectionInjectionHikma Pharmaceuticals USA, Inc.NeurologyUnavailableCurrent2018-05-03
Morphine Sulfate InjectionInjectionHikma Pharmaceuticals USA, Inc.Analgesia/AddictionAvailableCurrent2017-11-03
Morphine Sulfate InjectionInjectionHikma Pharmaceuticals USA, Inc.Analgesia/AddictionAvailableCurrent2017-11-03
Methotrexate Sodium InjectionInjectionHikma Pharmaceuticals USA, Inc.RheumatologyAvailableCurrent2023-03-13
Lorazepam InjectionInjectionHikma Pharmaceuticals USA, Inc.NeurologyUnavailableCurrent2018-09-05
Lorazepam InjectionInjectionHikma Pharmaceuticals USA, Inc.NeurologyUnavailableCurrent2018-09-05
Morphine Sulfate InjectionInjectionHikma Pharmaceuticals USA, Inc.Analgesia/AddictionAvailableCurrent2017-11-03
Etomidate InjectionInjectionHikma Pharmaceuticals USA, Inc.AnesthesiaAvailableCurrent2022-10-05
Promethazine Hydrochloride InjectionInjectionHikma Pharmaceuticals USA, Inc.Analgesia/AddictionUnavailableCurrent2023-11-21
Atropine Sulfate InjectionInjectionHikma Pharmaceuticals USA, Inc.AnesthesiaAvailableCurrent2023-12-20
Morphine Sulfate InjectionInjectionHikma Pharmaceuticals USA, Inc.Analgesia/AddictionAvailableCurrent2017-11-03
Meperidine Hydrochloride InjectionInjectionHikma Pharmaceuticals USA, Inc.Analgesia/AddictionAvailableCurrent2025-05-30
Page 26 of 47
← PrevNext →

Data: U.S. FDA openFDA drug/shortages API, which lists activeshortages (Current or To Be Discontinued) — it carries no per-record cause field, so SPEQ makes no root-cause claim on individual drugs; the quality framing above is cited FDA context. openFDA publishes shortage data for drugs only; SPEQ’s cross-industry coverage lives in the recall Explorer(drug, device & food).